Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Autologous Cord Blood Mononuclear Cells for Treatment of Bronchopulmonary Dysplasia in Extremely Preterm Neonates: a Non-Randomized Case-Control Trial Study

NCT05071638 is registered in ClinicalTrials.gov with Guangdong Women and Children Hospital as lead sponsor.

NCT NCT05071638
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05071638 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Autologous Cord Blood Mononuclear Cells for Treatment of Bronchopulmonary Dysplasia in Extremely Preterm Neonates: a Non-Randomized Case-Control Trial Study
Lead sponsor
Guangdong Women and Children Hospital
Phase
Phase 3
Overall status
Unknown status
Start date
October 1, 2021
Completion date
September 30, 2023
Enrollment
76 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bpd